Vtama is projected to contribute $150 million in 2025 revenue, supported by its new label approval for atopic dermatitis. Nexplanon is expected to reach at least $1 billion in revenue for 2025. Q4 ...

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

Thanks to a rising prevalence of hearing loss and awareness of rehabilitation options. The cochlear implants market is projected to hit $4.73b by 2030 at a compound annual growth rate of 9.2%, ...

ReadySet Surgical, a health tech company aiming to streamline the surgical supply chain, has its sights set on expansion ...

Envista provided 2025 guidance with core growth expected in the range of 1% to 3%, adjusted EBITDA margin at approximately 14%, and adjusted EPS between $0.95 and $1.05. The company plans to allocate ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...

Additionally, the expansion of telemedicine and remote patient monitoring ... the medical device market is experiencing rapid innovation, including smart implants, 3D-printed prosthetics, and ...